Cardiorespiratory effects of O-isobutyl S-[2-(diethylamino)-ethyl] methylphosphonothioate: A structural isomer of VX

Journal of Applied Toxicology

Volumn 18, Issue 5, 1998, Pages 337-347

  Chang, F C T ^a   Gouty, S C ^a   Eder, L C ^a   Hoffman, B E ^a   Maxwell, D M ^a   Brecht, K M ^a  

^a US ARMY MEDICAL RESEARCH INSTITUTE OF CHEMICAL DEFENSE   (United States)

Author keywords

Acetylcholinesterase inhibitor; Cardiovascular function; Guinea pigs; Novel chemical warefare agent; Respiration; VX isomer

Indexed keywords

METHYLPHOSPHONIC ACID; URETHAN;

ACIDEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; BRADYCARDIA; BRADYPNEA; CARDIOVASCULAR FUNCTION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; ELECTROCORTICOGRAPHY; GUINEA PIG; HEART ARRHYTHMIA; HEART FAILURE; HYPERCAPNIA; HYPERSALIVATION; HYPOTENSION; HYPOXEMIA; LUNG FUNCTION; MALE; NERVE FUNCTION; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY FAILURE;

ACIDOSIS; ANIMALS; ARRHYTHMIA; BLOOD PRESSURE; BLOOD-BRAIN BARRIER; CARBON DIOXIDE; CHEMICAL WARFARE AGENTS; DIAPHRAGM; ELECTROENCEPHALOGRAPHY; GUINEA PIGS; HEART; MALE; ORGANOTHIOPHOSPHORUS COMPOUNDS; OXYGEN; RESPIRATION; TIME FACTORS;

EID: 0031684256     PISSN: 0260437X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1263(1998090)18:5<337::AID-JAT518>3.0.CO;2-G     Document Type: Article

References (33)

1. R. L. Maynard and F. W. Beswick, Organophosphorus compounds as chemical warfare agents. In Clinical and Experimental Toxicology of Organophosphates and Carbamates, ed. by B. Ballantyne and T. C. Marrs, pp. 373-385. Butterworth-Heinemann, Oxford (1992).
2. L. L. Szafraniec, W. T. Beaudry and L. J. Szafraniec, Decontamination chemistry of Russian VX. In Proceedings of the Scientific Conference on Chemical and Biological Defense Research, Aberdeen Proving Ground, MD, 14-17 November 1995.
3. D. M. Maxwell, K. M. Brecht and I. Koplovitz, Characterization and treatment of the toxicity of O-isobutyl S-[2-(diethylamino)ethyl]methylphosphonothioate, a structural isomer of VX, in guinea pigs. J. Am. Coll. Toxicol. 15 (Suppl. 2), S78-S88 (1997).
4. M. A. Dunn and F. R. Sidell, Progress in medical defense against nerve agents. J. Am. Med. Assoc. 262, 649-652 (1989).
5. J. R. Keeler, C. G. Hurst and M. A. Dunn, Pyridostigmine used as nerve agent pretreatment under wartime conditions. J. Am. Med. Assoc. 266, 693-695 (1991).
6. L. Leadbeater, R. H. Inns and J. M. Rylands, Treatment of poisoning by soman. Fundam. Appl. Toxicol. 5, S225-S231 (1985).
7. K. J. Field, W. J. White and C. M. Lang, Anaesthetic effects of chloral hydrate, pentobarbitone and urethane in adult male rats. Lab. Anim. 27, 258-269 (1993).
8. 2 stimulating action on respiration in cats. J. Pharmacol. Exp. Ther. 92, 187-195 (1948).
9. F.-C. T. Chang and R. M. Harper, A procedure for chronic recording of diaphragmatic electromyographic activity. Brain Res. Bull. 22, 561-563 (1989).
10. F.-C. T. Chang, B. J. Benton, J. L. Salyer, R. E. Foster and D. R. Franz, Respiratory and cardiovascular effects of tetrodotoxin (TTX) in urethane-anesthetized guinea pigs. Brain Res. 528, 259-268 (1990).
11. F.-C. T. Chang, T. R. Scott and R. M. Harper, Methods of single unit recording from medullary neural substrates in awake, behaving animals. Brain Res. Bull. 21, 749-756 (1988).
12. D. G. Childers, Modern Spectrum Analysis. IEEE Press, New York (1978).
13. F.-C. T. Chang, B. J. Benton, R. A. Lenz and B. R. Capacio, Central and peripheral cardio-respiratory effects of saxitoxin (STX) in urethane-anesthetized guinea pigs. Toxicon 31, 645-664 (1993).
14. N. S. Cherniack, N. H. Edelman and S. Lahiri, Hypoxia and hypercapnia as respiratory stimulants and depressants. Respir. Physiol. 11, 113-126 (1971).
15. B. Ballantyne and T. C. Marrs, Clinical and Experimental Toxicology of Organophosphates and Carbamates. Butterworth-Heinemann, Oxford (1992).
16. A. Anzueto, G. G. Berdine, G. T. Moore, C. Gleiser, D. Johnson, C. D. White and W. G. Johanson, Pathophysiology of soman intoxication in primates. Toxicol. Appl. Pharmacol. 86, 56-68 (1986).
17. A. Anzueto, R. A. deLemos, J. Seidenfeld, G. Moore, H. Hamil, D, Johnson and S. G. Jenkinson, Acute inhalation toxicity of soman and sarin in baboons. Fundam. Appl. Toxicol. 14, 676-87 (1990).
18. D. R. Franz and R. Hilaski, Sequence of cardiorespiratory effects of soman altered by route of administration. Toxicol. Lett. 51, 221-225 (1990).
19. J. A. Lipp and T. J. Dola, Effect of atropine upon the cerebrovascular system during soman-induced respiratory depression. Arch. Int. Pharmacodyn. Ther. 235, 211-218 (1978).
20. D. L. Rickett, J. F. Glenn and E. T. Beers, Central respiratory effects versus neuromuscular actions of nerve agents. Neurotoxicology 7, 225-236 (1986).
21. F. Worek, A. Kleine, K. Falke and L. Szinicz, Arrhythmias in organophosphate poisoning: Effect of atropine and bispyridinium oximes. Arch. Int. Pharmacodyn. Ther. 329, 418-435 (1995).
22. F. Worek and L. Szinicz, Analysis of cardiovascular and respiratory effects of various doses of soman in guinea-pigs: efficacy of atropine treatment. Arch. Int. Pharmacodyn. Ther. 325, 96-112 (1993).
23. G. K. Adams, H. I. Yamamura and J. F. O'Leary, Recovery of central respiratory function following anticholinesterase intoxication. Eur. J. Pharmacol. 38, 101-112 (1976).
24. C. R. Hassler, R. R. Moutvic and D. W. Hobson, Long term arrhythmia analysis of primates pretreated with pyridostigmine, challenged with soman, and treated with atropine and 2-PAM. In Proc. 1989 Medical Defense Bioscience Review, pp. 479-482. US Department of Defense, Washington, DC (1989).
25. R. W. Brimblecombe, Drugs acting on central cholinergic mechanisms and affecting respiration. Pharmacol. Ther. 3, 5-74 (1977).
26. C. A. N. Evans, J. M. Reynolds, M. L. Reynolds and N. R. Saunders, The effect of hypercapnia on a blood-brain barrier mechanism on foetal sheep. J. Physiol. 255, 701-714 (1976).
27. Bradbury, M. The Concept of a Blood-Brain Barrier. Wiley, Chichester (1979).
28. C. J. Clemedson, H. Hartelius and G. Holmberg, The influence of carbon dioxide inhalation on the cerebral vascular permeability to trypan blue (the blood-brain barrier). Acta Pathol. Microbiol. Scand. 42, 137-149 (1958).
29. R. W. P. Cutler and C. F. Barlow, The effect of hypercapnia on brain permeability to protein. Arch. Neurol. 14, 54-63 (1966).
30. M. A. Goldberg, C. F. Barlow and L. J. Roth, The effects of carbon dioxide on the entry and accumulation of drugs in the central nervous system. J. Pharmacol. 131, 308-318 (1961).
31. M. A. Goldberg, C. F. Barlow and L. J. Roth, Abnormal brain permeability in carbon dioxide narcosis. Arch. Neurol. 9, 498-507 (1963).
32. S. C. Sørensen, The permeability to small ions of tight junctions between cerebral endothelial cells. Brain Res. 70, 174-178 (1974).
33. W. N. Aldridge and E. Reiner, Enzyme Inhibitors as Substrates, pp. 67-82. North Holland, Amsterdam (1972).